Yes, hypothyroidism can raise cortisol, but the mechanism is indirect and the size of the effect varies widely. When thyroid hormone falls, the hypothalamus increases its output of thyrotropin-releasing hormone (TRH), and TRH also stimulates corticotropin-releasing hormone (CRH). That extra CRH drives the pituitary to release more ACTH, which pushes the adrenal cortex to make more cortisol. The catch: in most people the rise is modest, often within the reference range, and the HPA axis compensates. Clinically significant hypercortisolism from hypothyroidism alone is uncommon. What matters is recognizing the overlap in symptoms and testing both axes correctly rather than assuming one explains the other.
The Mechanism: How Low Thyroid Hormone Raises CRH and ACTH
The link runs through the hypothalamus, not the thyroid gland. Thyroid hormone normally feeds back negatively on the hypothalamus and pituitary. When free T4 and T3 drop, that brake lifts, and TRH-producing neurons in the paraventricular nucleus fire harder. The same region houses CRH neurons, and TRH neurons project to them. More TRH means more CRH, and CRH is the master signal that tells the anterior pituitary to release ACTH.
ACTH then acts on the zona fasciculata of the adrenal cortex to increase cortisol synthesis. In laboratory and clinical studies, untreated hypothyroidism is associated with elevated 24-hour urinary free cortisol in a subset of patients, blunted cortisol suppression on dexamethasone testing, and a delayed cortisol response to ACTH stimulation. The pattern looks like mild central activation of the stress axis, not an adrenal tumor pumping out hormone.
A second route involves cortisol metabolism rather than production. Thyroid hormone regulates the enzyme 11-beta-hydroxysteroid dehydrogenase type 1, which converts inactive cortisone back to active cortisol inside tissues. In hypothyroidism, cortisol clearance slows, so circulating cortisol can rise even if adrenal output is normal. This is a clearance effect, not a secretion effect, and it tends to reverse quickly with thyroid replacement.
In plain terms: the thyroid and adrenal systems share a control room in the brain, and turning down thyroid output turns up the stress-hormone signal.
How Large Is the Cortisol Rise? Quantified Context
The magnitude is the part most explainers skip. In studies of overt hypothyroidism, mean 24-hour urinary free cortisol runs roughly 20 to 40 percent above euthyroid controls in the subgroup with measurable elevation, while serum cortisol at 8 a.m. often rises only 10 to 25 percent. Many patients show no rise at all. The reference range for morning serum cortisol is typically 5 to 25 micrograms per deciliter, and most hypothyroid patients stay inside it.
| Measure | Typical euthyroid value | Overt hypothyroid shift | Clinical significance |
|---|---|---|---|
| 8 a.m. serum cortisol | 5–25 mcg/dL | +10–25% in a subset | Usually stays in range |
| 24-hour urinary free cortisol | 10–55 mcg/24h | +20–40% in a subset | Can exceed upper limit |
| Cortisol after 1 mg dexamethasone | under 1.8 mcg/dL | Blunted suppression in some | Can mimic Cushing on testing |
| ACTH | 10–60 pg/mL | Mildly elevated or normal | Central, not adrenal, pattern |
| Cortisol clearance half-life | ~ 70–90 min | Prolonged | Raises exposure at same output |
The dexamethasone row matters most. A single 1 mg overnight dexamethasone suppression test screens for Cushing syndrome, and values above 1.8 mcg/dL are considered abnormal per the Endocrine Society's 2008 Cushing guideline. A meaningful minority of hypothyroid patients suppress incompletely, which can generate a false-positive screen. That is the non-obvious detail: the test you use to rule out Cushing can mislead when the thyroid is untreated.
Hypothyroidism vs. Cushing Syndrome: Overlapping Signs and a Comparison
The symptoms overlap enough that patients and clinicians confuse the two. Fatigue, weight gain, constipation, dry skin, depression, and slowed cognition appear in both. The distinguishing features are where the two conditions diverge, and those differences are reliable enough to guide testing.
| Feature | Hypothyroidism | Cushing syndrome |
|---|---|---|
| Weight change | Gain, 5–10 lb typical | Central gain, often 20+ lb |
| Blood pressure | Often normal or mildly high | High in ~ 80% of cases |
| Skin | Dry, coarse, cool | Thin, easy bruising, striae |
| Muscle | Cramps, weakness | Proximal wasting, 60%+ |
| Glucose | Usually normal | Impaired in 50–80% |
| Potassium | Normal | Low in many cases |
| First-line test | TSH, free T4 | Overnight dexamethasone, late-night salivary cortisol |
| Reversibility | Full with levothyroxine | Requires tumor-directed care |
The practical implication: order TSH and free T4 first when the picture could be either. If thyroid function is low, treat it and recheck cortisol studies after 8 to 12 weeks rather than chasing an adrenal diagnosis immediately. Most apparent hypercortisolism resolves with thyroid replacement alone.
The Treatment Timeline: What Normalizes and When
Cortisol axis changes do not correct overnight. Thyroid hormone has a long half-life and tissue effects lag behind serum levels. The table below reflects typical patterns seen in clinical practice and small prospective studies, not a guaranteed schedule for any individual.
| Time after starting levothyroxine | Expected change | What to measure |
|---|---|---|
| Week 1–2 | TSH begins to fall | Symptoms, heart rate |
| Week 4–6 | Free T4 reaches steady state | TSH, free T4 |
| Week 6–8 | Cortisol suppression often improves | Repeat dexamethasone if abnormal |
| Week 8–12 | Urinary free cortisol trends toward baseline | 24-hour urine if initially high |
| Month 3–6 | Full thyroid steady state | TSH, free T4, symptoms |
| Month 6+ | Cortisol axis usually normal if thyroid is normal | Only if symptoms persist |
Doses matter for the timeline. A starting levothyroxine dose of 25 to 50 micrograms daily is common in older adults or those with cardiac disease, while younger patients may start at 1.6 micrograms per kilogram per day. Under-replacement slows the cortisol correction, and over-replacement can itself cause palpitations, anxiety, and insomnia that mimic hypercortisolism. That is the reconciliation point: a TSH above 4.5 milli-international units per liter suggests under-treatment, a TSH below 0.4 suggests over-treatment, and cortisol testing is only interpretable when TSH sits in the 0.4 to 4.5 range.
Red Flags That Change the Diagnosis
Most hypothyroid patients with mildly elevated cortisol need no adrenal workup. Some presentations demand it, and these are the ones to escalate.
- Cortisol above 50 micrograms per deciliter with rapid weight gain, purple striae, or new hypertension
- Severe headache, visual field loss, or sudden pituitary-type symptoms
- Persistent hypercortisolism after 3 to 6 months of adequate thyroid replacement
- Adrenal crisis signs: vomiting, low blood pressure, confusion, darkening skin
- Hypoglycemia or low sodium with high cortisol and an ACTH that does not fit
- A thyroid nodule or goiter with hypercortisolism, raising concern for multiple endocrine neoplasia
These features point away from simple hypothyroid-driven cortisol elevation and toward a separate pituitary or adrenal process.
Common Misconceptions About Hypothyroidism and Cortisol
The first misconception is that hypothyroidism causes Cushing syndrome. It does not. It can produce biochemical findings that mimic Cushing on a screening test, but true Cushing syndrome requires sustained, autonomous hypercortisolism with a specific source, such as a pituitary adenoma, an adrenal adenoma, or ectopic ACTH. The estimated prevalence of Cushing is roughly 40 to 70 cases per million, versus hypothyroidism at 3,700 to 17,000 per million depending on iodine status. The base rates strongly favor thyroid disease when both are considered.
The second misconception is that treating cortisol is necessary in hypothyroidism. In the vast majority of cases, levothyroxine alone normalizes the axis. Adding an adrenal-blocking drug to a patient whose cortisol is high only because of low thyroid risks iatrogenic adrenal insufficiency.
The third misconception concerns the direction of the relationship. The thyroid-adrenal link runs both ways. Untreated adrenal insufficiency can impair thyroid hormone production and cause a low T4 state, and severe illness of any kind can suppress the thyroid axis. That bidirectional relationship is why testing one axis without the other can produce a misleading picture.
What to Actually Do: Practical Steps
Start with the right tests. A TSH and free T4 establish thyroid status, and a morning serum cortisol or a 1 mg overnight dexamethasone suppression test screens the adrenal axis. Do not order a random cortisol in the afternoon, because the diurnal rhythm makes it uninterpretable.
Treat thyroid disease before chasing cortisol. Start levothyroxine at an age-appropriate dose, recheck TSH at 6 to 8 weeks, and adjust in 12.5 to 25 microgram steps. Repeat cortisol testing only if symptoms persist after thyroid levels normalize.
Avoid supplements and medications that distort both axes. Biotin at doses of 5 milligrams or more can falsely lower TSH and free T4 immunoassays. Estrogen raises thyroid-binding globulin and shifts free hormone measurements. Opioids and glucocorticoids suppress the HPA axis directly. Disclose all of these before testing.
Consider the edge case of autoimmune polyendocrine syndrome. When hypothyroidism and adrenal insufficiency coexist, as in autoimmune polyglandular syndrome type 2, starting levothyroxine before replacing glucocorticoids can precipitate an adrenal crisis. If cortisol is low and ACTH is high, treat the adrenal insufficiency first or simultaneously, not after.
Limitations and What Remains Uncertain
The evidence base for hypothyroid-driven cortisol elevation is mostly small observational studies, not large randomized trials. The exact proportion of patients with abnormal dexamethasone suppression varies across studies from under 10 percent to over 40 percent, largely because of differences in assay methods, patient selection, and how long hypothyroidism had gone untreated. The mechanism is well established at the level of TRH and CRH biology, but the individual magnitude is not predictable from TSH alone.
The 11-beta-hydroxysteroid dehydrogenase route is plausible and supported by tissue studies, but its contribution to circulating cortisol in humans is not precisely quantified. The clearance effect and the central drive likely operate together, and separating them in a single patient is not currently possible with routine tests.
The practical takeaway is stable even where the numbers are uncertain. Hypothyroidism can raise cortisol through central HPA activation and slowed cortisol clearance. The rise is usually small, often within range, and reverses with thyroid replacement. Screen both axes when symptoms overlap, treat the thyroid first, and reserve a full adrenal workup for patients whose hypercortisolism persists after thyroid levels normalize or who carry red-flag features.